> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Panel to Review Pain Drug
- URL: https://www.fdaweb.com/panel-to-review-pain-drug/
- Published: 2018-09-11T12:00:00.000Z
- Updated: 2026-09-15T00:31:15.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5142316

*Federal Register* notice: FDA has announced a 10/11 Anesthetic and Analgesic Drug Products Advisory Committee meeting. Panel members are scheduled review a Trevena NDA for oliceridine 1mg/ml injection for managing moderate-to-severe acute pain in adult patients for whom an intravenous opioid is warranted. The committee will also be asked to discuss efficacy and safety data and benefit-risk considerations. To view the notice, click [here](https://www.gpo.gov/fdsys/pkg/FR-2018-09-11/pdf/2018-19667.pdf?ref=fdaweb.com).